|
Please check back for updates! |
| |
all times are approximate and subject to change without notice |
| |
Day 1 - Monday, September 9, 2013 |
| 7:55 |
Welcome & Opening Remarks |
| |
Two Concurrent Tracks |
| |
Joint Plenary Keynote Session, Part I |
| 8:00 |
Jeffrey Nye
Vice President Neuroscience External
Partnering Strategy
Johnson & Johnson
|
| 8:45 |
Li-Huei Tsai
Professor and Director, Picower Institute for
Learning and Memory
Massachusetts Institute of Technology
|
| 9:30 |
Rajesh Ranganathan
Director of the Office of Translational
Research, NINDS
NIH
|
| 10:15 |
Networking and Refreshment Break |
| |
Break into Individual Conferences -
click the conference title for a detailed agenda |
| Conference Titles |
7th Neurodegenerative Conditions Research and Development |
6th CNS Partnering and Deal-Making |
| 11:15 |
Session I
Novel Therapeutic Targets and Approaches in Alzheimer's Disease |
Session I
Licensing & Partnering Strategies
Part I |
| 12:30 |
Lunch on Your Own |
| 2:00 |
Session I
Novel Therapeutic Targets and Approaches in Parkinson's Disease |
Session I
Licensing & Partnering Strategies
Part I |
| 3:15 |
Afternoon Networking & Coffee Break |
| 3:45 |
Session I
Novel Therapeutic Targets and Approaches in Neurodegenerative Conditions |
Session II
Recent Advances in CNS Development
Part I |
| 5:30 |
Networking Reception and Poster Session |
| |
|
| |
Day 2 - Tuesday, September 10, 2013 |
| 7:30 |
Continental Breakfast |
| |
Two Concurrent Tracks |
| |
Joint Session: Recent Advances in Neuroscience Research |
| 8:00 |
Frank LaFerla
Chancellor's Professor and Chair, Neurobiology
and Behavior School of Biological Sciences Director, Institute for Memory
Impairments and Neurological Disorders (MIND)
University of California, Irvine
|
| 8:25 |
TBA |
| 8:50 |
Mehmet Yanik
Group leader, Associate Professor,
High-Throughput Neurotechnology Group
MIT
|
| 9:15 |
TBA |
| 9:40 |
Networking and Refreshment Break |
| |
Break into Individual Conferences -
click the conference title for a detailed agenda |
| Conference Titles |
7th Neurodegenerative Conditions Research and Development |
6th CNS Partnering and Deal-Making |
| 10:00 |
Session II
Biomarkers: Translation from Discovery to Clinical |
Session II
Recent Advances in CNS Development
Part II |
| 11:55 |
Lunch Provided by GTC |
| 1:00 |
Joint Session: Licensing & Partnering Strategies, Part II |
| 1:00 |
Tracey Mumford, Senior Associate
Director, Research Partnerships, Michael J. Fox Foundation
|
| 1:25 |
Carrie Jones, Director, In Vivo
and Translational Pharmacology, Vanderbilt University Medical Center |
| 1:50 |
Panel Discussion: Role of Patient
Groups
|
| 2:35 |
Panel Discussion: Partnering in
the AD, PD and Other Cognitive Disorders. How Have Things Changed? |
| 3:20 |
Conferences Conclude |
| |
all times are approximate and subject to change without notice |
